Search results for " Disability"

showing 10 items of 673 documents

Care management in a French cohort with Down syndrome from the AnDDI-Rares/CNSA study.

2021

Down syndrome (DS) is a genetic neurodevelopmental disorder. In individuals with DS, a multidisciplinary approach to care is required to prevent multiple medical complications. The aim of this study was to describe the rehabilitation, medical care, and educational and social support provided to school-aged French DS patients with varying neuropsychological profiles. A mixed study was conducted. Quantitative data were obtained from a French multicentre study that included patients aged 4-20 years with diverse genetic syndromes. Qualitative data were collected by semi-structured face-to-face interviews and focus groups. Ninety-five DS subjects with a mean age of 10.9 years were included. Sixt…

Occupational therapyMalemedicine.medical_specialtyDown syndromeAdolescentWaiting Listsmedicine.medical_treatmentHealth Services Accessibility03 medical and health sciencesSocial supportYoung Adult0302 clinical medicineIntellectual disabilityGeneticsmedicineHumansChildGenetics (clinical)030304 developmental biologyPsychomotor learning0303 health sciencesRehabilitationbusiness.industryMultidisciplinary careNeurological RehabilitationSocial SupportGeneral Medicinemedicine.diseaseFocus group3. Good healthEducation of Intellectually DisabledPatient Care ManagementEducational supportFamily medicineChild PreschoolCohortIntellectual deficiencyFemaleInterdisciplinary CommunicationFranceDown Syndromebusiness030217 neurology & neurosurgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyEuropean journal of medical genetics
researchProduct

“ALL TERMS HAVE A NEGATIVE APPENDIX” PARENTS OF OFFSPRING WITH INTELLECTUAL DISABILITY (ID) AND THEIR EXPERIENCES WITH NAMING THIS DIAGNOSIS – AN INT…

2013

16 parents with offspring with ID were interviewed, using a guide that asks for their experiences of the naming the ID-diagnosis, of different labels that have been used, of how labels have changed during the last half century, of how they explain label-changes, and of whether some of the explanations might be considered substantial. Generally there is an overlap with findings of similar studies among professionals. However, parents add new nuances and emphasize in a more thorough way the substantiality of two causal explanations of the changes: the impact of ethical training and the influence of users

OffspringIntellectual disabilityeducationmedicineInterview studysense organsmedicine.diseasePsychologyskin and connective tissue diseasesDevelopmental psychologyEducation Reform in Comprehensive School: Education Content Research and Implementation Problems
researchProduct

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS

2020

ObjectiveWe applied longitudinal 3T MRI and advanced computational models in 2 independent cohorts of patients with early MS to investigate how white matter (WM) lesion distribution and cortical atrophy topographically interrelate and affect functional disability.MethodsClinical disability was measured using the Expanded Disability Status Scale Score at baseline and at 1-year follow-up in a cohort of 119 patients with early relapsing-remitting MS and in a replication cohort of 81 patients. Covarying patterns of cortical atrophy and baseline lesion distribution were extracted by parallel independent component analysis. Predictive power of covarying patterns for disability progression was tes…

OncologyAdultMalemedicine.medical_specialtySupport Vector Machine41Article312LesionWhite matterText miningMultiple Sclerosis Relapsing-RemittingInternal medicineCerebellumMedicineHumansLongitudinal StudiesCerebral CortexExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisMagnetic resonance imagingMiddle Agedmedicine.diseasePrognosisMagnetic Resonance ImagingWhite MatterHyperintensitymedicine.anatomical_structureNeurologyCohortDisease ProgressionFemaleNeurology (clinical)medicine.symptomAtrophybusinessNeurology® Neuroimmunology & Neuroinflammation
researchProduct

Apolipoprotein E genotype does not influence the progression of multiple sclerosis

2003

OBJECTIVE: To investigate the association between apolipoprotein E (APOE) polymorphisms and the progression of MS. METHODS: We investigated 428 subjects affected by clinically defined MS, with a disease duration of at least three years. We collected data concerning the age at onset of MS, clinical type, disease duration and disability according to the expanded disability status scale (EDSS). We also calculated the progression index (PI) to evaluate disease progression. APOE genotyping and the -491 A/T polymorphism of the APOE promoter were determined. RESULTS: No association was observed between the APOE epsilon4 allele and clinical characteristics of our study population. We also investiga…

OncologyApolipoprotein EAdultMalemedicine.medical_specialtyMultiple SclerosisGenotypeAdolescentOdds Ratio; Polymorphism Genetic; Chi-Square Distribution; Humans; Disease Progression; Apolipoproteins E; Genotype; Multiple Sclerosis; Adult; Confidence Intervals; Adolescent; Statistics Nonparametric; Female; MalePopulationAPOE polymorphismBiologyStatistics NonparametricApolipoproteins EGeneticPolymorphism (computer science)Internal medicineGenotypeMultiple SclerosimedicineOdds RatioConfidence IntervalsHumansNonparametricPolymorphismeducationGenotypingAPOE promotereducation.field_of_studyExpanded Disability Status ScalePolymorphism GeneticChi-Square DistributionMS progressionStatisticsOdds ratioNeurologyImmunologyDisease ProgressionPopulation studylipids (amino acids peptides and proteins)FemaleSettore MED/26 - NeurologiaNeurology (clinical)Confidence IntervalHuman
researchProduct

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML

2017

Objective:To examine retrospectively the effects of plasmapheresis (PLEX) on the survival and clinical outcomes of patients with multiple sclerosis (MS) and natalizumab (NTZ)–associated progressive multifocal leukoencephalopathy (PML).Methods:The medical literature was searched for the terms natalizumab and progressive multifocal leukoencephalopathy. A total of 193 international and 34 Italian NTZ-PML cases were included. Clinical outcome was determined by comparing the patients' clinical status at PML diagnosis with status after PML resolution. The effects on survival and clinical outcome of PLEX, sex, age, country, pre-PML Expanded Disability Status Scale score, NTZ infusion number, prior…

OncologyMaleJC virus030204 cardiovascular system & hematologymedicine.disease_causeLeukoencephalopathyDisability Evaluationneurology (clinical); progressive multifocal leukoencephalopathy; reconstitution inflammatory syndrome; multiple-sclerosis0302 clinical medicineNatalizumabImmunologic FactorLeukoencephalopathyRetrospective StudieMultiple SclerosiMedicinePlasmapheresiAdult; Disability Evaluation; Female; Humans; Immunologic Factors; Leukoencephalopathy Progressive Multifocal; Male; Middle Aged; Multiple Sclerosis; Natalizumab; Plasmapheresis; PubMed; Retrospective Studies; Statistics Nonparametric; Treatment OutcomeProgressive multifocal leukoencephalopathyNatalizumabStatisticsLeukoencephalopathy Progressive MultifocalPlasmapheresisMiddle AgedTreatment OutcomeFemaleSettore MED/26 - Neurologiamedicine.drugHumanAdultmedicine.medical_specialtyPubMedMultiple SclerosisProgressive MultifocalStatistics Nonparametric03 medical and health sciencesImmune reconstitution inflammatory syndromeInternal medicineHumansImmunologic FactorsNonparametricprogressive multifocal leukoencephalopathy multiple sclerosis side effectRetrospective StudiesExpanded Disability Status Scalebusiness.industryMultiple sclerosisRetrospective cohort studymedicine.diseaseImmunologyNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Deciphering Multiple Sclerosis Progression

2021

Esclerosi múltiple; Neurodegeneració Esclerosis múltiple; Neurodegeneración Multiple sclerosis; Nneurodegeneration Multiple sclerosis (MS) is primarily an inflammatory and degenerative disease of the central nervous system, triggered by unknown environmental factors in patients with predisposing genetic risk profiles. The prevention of neurological disability is one of the essential goals to be achieved in a patient with MS. However, the pathogenic mechanisms driving the progressive phase of the disease remain unknown. It was described that the pathophysiological mechanisms associated with disease progression are present from disease onset. In daily practice, there is a lack of clinical, ra…

Oncologymedicine.medical_specialty:Other subheadings::Other subheadings::/physiopathology [Other subheadings]:Otros calificadores::Otros calificadores::/fisiopatología [Otros calificadores]Esclerosi múltiple - Propensió:Genetic Phenomena::Genotype::Genetic Predisposition to Disease [PHENOMENA AND PROCESSES]ReviewDiseaseneurofilamentEsclerosi múltiple - Fisiologia patològicamultiple sclerosislcsh:RC346-429Sistema nerviós - Degeneració03 medical and health sciences0302 clinical medicineDegenerative diseaseInternal medicinemedicineIn patient030212 general & internal medicine:enfermedades del sistema nervioso::enfermedades neurodegenerativas [ENFERMEDADES]lcsh:Neurology. Diseases of the nervous system:fenómenos genéticos::genotipo::predisposición genética a la enfermedad [FENÓMENOS Y PROCESOS]Expanded Disability Status Scalebusiness.industryMultiple sclerosisNeurodegenerationDisease progressionneurodegeneration:Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases CNS::Multiple Sclerosis [DISEASES]medicine.diseaseClinical trialprogressive multiple sclerosisNeurology:Nervous System Diseases::Neurodegenerative Diseases [DISEASES]:enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES]Neurology (clinical)business030217 neurology & neurosurgeryMRI
researchProduct

Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current trea…

2018

Approved medications for relapsing-remitting multiple sclerosis have shown to be effective in terms of their anti-inflammatory potential. However, it is also crucial to evaluate what long-term effects a patient can expect from current MS drugs in terms of preventing neurodegeneration. Here we aim to provide an overview of the current treatment strategies in MS with a specific focus on potential neuroprotective effects. Areas covered: Randomized, double-blind and placebo or referral-drug controlled phase 2a/b and phase 3 trials were examined; non-blinded phase 4 studies (extension studies) were included to provide long-term data, if not otherwise available. Endpoints considered were expanded…

Oncologymedicine.medical_specialtyAnti-Inflammatory AgentsNeuroimagingDiseaseNeuropsychological TestsPlaceboNeuroprotectionDisability Evaluation03 medical and health scienceschemistry.chemical_compoundMultiple Sclerosis Relapsing-Remitting0302 clinical medicineInternal medicineTeriflunomidemedicineHumansPharmacology (medical)030212 general & internal medicineNeuronsExpanded Disability Status Scalebusiness.industryGeneral NeuroscienceMultiple sclerosismedicine.diseaseMagnetic Resonance ImagingFingolimodNeuroprotective AgentsTreatment OutcomeMultiple sclerosis functional compositechemistryDisease ProgressionNeurology (clinical)businessImmunosuppressive Agents030217 neurology & neurosurgerymedicine.drugExpert Review of Neurotherapeutics
researchProduct

Oral health-related quality of life after dental treatment in patients with intellectual disability

2020

Background The influence of dental treatment on oral health-related quality of life (OHRQOL) has rarely been evaluated in patients with intellectual disability (ID) through validated questionnaires. The aim of this study was to estimate the changes on OHRQOL in patients with ID after the implementation of an institutional dental treatment program under general anesthesia using the Franciscan Hospital for Children Oral Health-Related Quality of Life questionnaire (FHCOHRQOL-Q). Material and Methods A prospective longitudinal study was conducted on 85 patients (mean age=24.85 years) classified according to DSM-V whose parents/caregivers completed the FHC-OHRQOL-Q. We analyzed the changes in t…

Oral health-related quality of lifeLongitudinal studyGeneral anesthesiaDentistryOral HealthDental CariesOral health03 medical and health sciences0302 clinical medicineQuality of lifeIntellectual DisabilitySurveys and QuestionnairesIntellectual disabilityHumansMedicineIn patientLongitudinal StudiesProspective StudiesChildProspective cohort studySpecial needsGeneral Dentistrybusiness.industryResearchDMFT Index030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in Dentistrymedicine.diseasestomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASDental treatmentQuality of LifeSurgeryMultiple linear regression analysisFranciscan Hospital for Children Oral Health-Related Quality of Life questionnairebusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

¿Hay diferencias entre las actitudes hacia la conducta sexual que tienen las personas con discapacidad intelectual y las de los profesionales que tra…

2020

Las actitudes hacia la sexualidad constituyen uno de los elementos cognitivo-emocionales más determinantes del funcionamiento sexual. En este sentido, la sexualidad de las personas con discapacidad intelectual (DI) está fuertemente influenciada por diversos mitos, estereotipos y prejuicios que repercuten en la perpetuación de ciertas actitudes negativas que limitan sus vivencias sexuales. El objetivo de este estudio es analizar las actitudes hacia la conducta sexual de las personas con discapacidad intelectual que poseen las propias personas que integran este colectivo y los profesionales que trabajan con ellos. Para ello, se utiliza la Escala de percepción sexual para personas con discapac…

Oral sexSexual functioningbusiness.industryIntellectual disabilitymedicineHuman sexualityMythologyPsychologymedicine.diseasebusinessSocial psychologyReproductive healthRevista INFAD de Psicología. International Journal of Developmental and Educational Psychology.
researchProduct

Coping with Burnout Symptoms through Task Significance in Professionals Working with Individuals with Intellectual Disability

2021

ABSTRACT This study examined an intervention that links task significance (one’s job has a positive impact on other people) to burnout symptoms of professionals working in organizations for individuals with intellectual disability. Professionals assigned to the experimental condition participated in teams designed to enhance the positive impact of their work on others (task significance). To do so, teams focused on a task to improve the quality of life of individuals with intellectual disability. Professionals assigned to the control condition did not participate in these teams, and they continued with their usual work. All the participating professionals answered a questionnaire abou…

Organizational Behavior and Human Resource ManagementCoping (psychology)Social Psychologylcsh:BF1-990educationIntellectual disabilityBurnoutteamsTask (project management)Teamstask significanceCynicismIntervention (counseling)Intellectual disabilitymedicineBurnoutPractical implicationsburnoutprofessionalsProfessionalsmedicine.diseasehumanitieslcsh:Psychologyintellectual disabilityMixed-design analysis of varianceTask significancePsychologypsychological phenomena and processesClinical psychologyRevista de Psicología del Trabajo y de las Organizaciones
researchProduct